Navigation Links
Pascal Metrics Announces Patient Safety Culture Services Offering
Date:12/2/2008

WASHINGTON, Dec. 2 /PRNewswire-FirstCall/ -- Today Pascal Metrics Inc. publicly announces its offering of patient safety culture and risk management services for hospitals and healthcare systems. Serving clients since 2007, Pascal Metrics rapidly has become a worldwide leader for clients seeking to comply with Joint Commission and other regulatory requirements, to reduce costs, and - by making healthcare more reliable - to make patients safer from medical failure and errors.

According to Dr. Michael Leonard, who co-leads Pascal's clinical group, "We find hospitals recognizing that regulatory compliance, while critical to achieving a minimum of safe care, is insufficient to implement systematic patient safety programs that measurably improve culture and reduce risk."

Pascal Metrics delivers the only solution that commercially supports both of the major scientifically-validated patient safety culture surveys: the Safety Attitudes Questionnaire (SAQ) and the Agency for Healthcare Research and Quality (AHRQ) Hospital Survey on Patient Safety Culture. More broadly, Pascal Metrics offers a field-leading range of metrics and analytics, including a pioneering observation service that tracks behavioral markers.

Dr. Allan Frankel, co-leader of Pascal's clinical group and inventor of WalkRounds(TM), sees "scientifically-rooted and clinically-sound observation as a powerful component of cultural assessment, insofar as there is deep training, standards-based implementation, and expert support."

Acknowledged as a leading innovator in the field, Pascal Metrics brings together academic research, clinical experience, and healthcare technology to provide metrics and analytics in improving the culture of safety and quality in high-risk environments. Relying on Pascal Metrics' software-as-a-service (SaaS) solution, senior and clinical leaders implement data-driven interventions and track cultural impro
'/>"/>

SOURCE Pascal Metrics Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. OPKO Health Appoints Pascal J. Goldschmidt to Board of Directors
2. End-to-End HR Performance Benchmarks: Metrics That Will Help Turn the HR Cost Center into a Productivity Driver
3. VivoMetrics LifeShirt Going to South Pole to Uncover Clues to High-Altitude Illness
4. HR Under the Microscope: Metrics to Drive Costs Down Across HR Functions
5. SAIC to Collaborate with UK Biometrics Institute
6. New Pharmaceutical Sales Force Communication Metrics: Nearly 6 Weeks of Sales Time per Rep Wasted Each Year
7. Animetrics Selects Kirk Communications as Agency of Record
8. HR Metrics From the Field: Outsourcing The Right Processes for Better Efficiencies
9. Oncology Metrics Launches the National Practice Benchmark: One in a Series of Initiatives to Help Community Oncology Practices Better Measure Operational and Financial Performance
10. Using HR Performance Metrics to Optimize Operations and Profits
11. Using HR Performance Metrics to Drive Costs Down Across HR Functions

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/10/2009)... WAVE (Whole-Body Advanced Vibration Exer...cutting edge vibration exercise technology into So...guay. All three of WAVE’s revolutionary vibr...tour Plus, are now available in South America. , ...-- WAVE (Whole-Body Advanced Vibration Exercise), ...
(Date:11/10/2009)... University Rollins School of Public Health resear... the American Public Health Association,s annual m...mined compliance with national recommendations tha... minutes of their arrival to the Emergency Departm...ndings from Emory scientists are highlighted below...
(Date:11/9/2009)...er Awareness Month Highlighted During Broadcast ,... Lung Cancer Alliance (LCA) announced that LCA sta...ll for the New York Stock Exchange(TM) (NYSE) tomo.../www.newscom.com/cgi-bin/prnh/20081016/LCALOGO ) ...d LCA-NY advocate, Richard Heimler will mark the e...
(Date:11/9/2009)..., Nov. 9 The Churchill Centre to...r Leadership to J.W. "Bill" Marriott for his lifel...ressive free market practices and fostering an ope...riott will receive his award at a ceremony and din... Four Seasons Hotel. ,, "This is a testament t...
(Date:11/9/2009)...n and women almost equally, study finds, , ...y used clot-dissolving drug Plavix (clopidogrel) w...s of major clinical trials has found. , "After ...ing both men and women with this very important dr...ovascular thrombosis at New York University Langon...
Breaking Medicine News(10 mins):Health News:WAVE's Revolutionary Whole-Body Advanced Vibration Exercise Is Now Available in South America 2Health News:Some chest pain patients wait longer than 10 minutes to see ER physician 2Health News:Lung Cancer Alliance Staff and Advocates to Ring Closing Bell of New York Stock Exchange(TM) 2Health News:J.W. 'Bill' Marriott to Receive Churchill Centre Award For Leadership 2Health News:No Gender Gap Found for Clot-Busting Drug 2Health News:No Gender Gap Found for Clot-Busting Drug 3
...nd the importance of a smooth-running circadian cl...rhythms// from the natural cycle of light and dark...inal photoreceptors that relay signals to the supr... set indirectly through SCN-dependent biological r...
... caused primarily by vehicle exhausts, coal-fired ...ce the risk of developing// heart disease, says a ...ersity of Washington and other researchers found t...health magazine WebMD. Researchers followed ...
...st outbreak of the H5N1 bird flu virus in the EU s...ed positive//. But experts say the mild winter mig...missioner Markos Kyprianou urged all member states...ding to his spokesman Philip Tod. An EU-app...
...ns are to blame for the brain disease. According t...er related brain disorders// may be caused by a vi...s prions, that scientists think are responsible. ...e, but found no traces of the particles in uninfec...
...es and has been used to prevent gangrene, treat hi...en believed// by some to have cancer-fighting prop...f Nottingham are leading a new pilot study to see ...arch will look at whether taking garlic capsules c...
...als, coronary artery bypass surgery performed on a...chine//, is a safe option that leads to fewer nega... is featured in Journal of Cardiac Surgery. “...ung machine,” says author Dr. Shahzad Raja. “Howev...
Other Medicine News:Health News:Researchers Investigate Gene Linked With Circadian Liver Clock 2Health News:Researchers Investigate Gene Linked With Circadian Liver Clock 3Health News:Virus may Be the Cause of Mad Cow 2Health News:Garlic Hope in Infection Fight 2
(Date:11/9/2009)...tCall/ -- Monsanto Company (NYSE: MON ) and Pfize... entered into an agreement for Monsanto to acquire...ated in Chesterfield, Mo. Under the terms of the ... Pfizer for $435 million to be paid over time, and...rfield Village through a lease agreement, primaril...
(Date:11/9/2009)...all/ -- Boston Scientific Corporation (NYSE: BSX ...ardiac resynchronization therapy defibrillator (CR...fibrillator (ICD) in Japan. These devices were ap...nd Welfare (MHLW) in August and received reimburse...e the result of a multi-year research and developm...
(Date:11/9/2009)...Access MediQuip, LLC, the nation,s first and large...ce management solutions to the healthcare industry...ate headquarters to Lake Mary, Florida. The move,...cludes a major expansion of the Primera Blvd, Lake...and relocation and expansion of the Houston facili...
Breaking Medicine Technology:Monsanto to Purchase Chesterfield Village Research Center From Pfizer 2Monsanto to Purchase Chesterfield Village Research Center From Pfizer 3Boston Scientific's Most Advanced Devices to Treat Heart Failure and Sudden Cardiac Death Now Available in Japan 2Boston Scientific's Most Advanced Devices to Treat Heart Failure and Sudden Cardiac Death Now Available in Japan 3Boston Scientific's Most Advanced Devices to Treat Heart Failure and Sudden Cardiac Death Now Available in Japan 4Access MediQuip Moves Company Headquarters to Lake Mary, Florida 2Trubion Announces Dates for Second Quarter and First Half 2009 Earnings Conference Call 13296 1Trubion Announces Dates for Second Quarter and First Half 2009 Earnings Conference Call 13296 2Cancer Survivors Face Tough Road Long After Treatment Ends 53273 1Cancer Survivors Face Tough Road Long After Treatment Ends 53273 2Cancer Survivors Face Tough Road Long After Treatment Ends 53273 3Tevas Forum Draws Key Pennsylvania Healthcare Leaders 53270 1Tevas Forum Draws Key Pennsylvania Healthcare Leaders 53270 2
...) for hepatitis C and LymphoStat-B(R) for lupus on...in 2010 -,- ABthrax(TM) for inhalation anthrax on ...strengthened with investments in oncology portfoli...ive - - GSK to advance darapladib to Phase 3 ...man Genome Sciences,Inc. (Nasdaq: HGSI ) today wi...
...alif., May 27 Epeius Biotechnologies,( http://www...lts of a Phase,I Feasibility Study of sequential t... Reximmune-C -- for cancer vaccination will be pre...2008 (J Clin Oncol 26:3077, 2008).,Rexin-G and Rex...ticles,bearing a cytocidal cyclin G1 gene and a gr...
Other Medicine Technology:Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives 2Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives 3Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives 4Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives 5Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives 6Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives 7Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives 8Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives 9Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives 10Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives 11TARGETED GENE DELIVERY SIGNALS CANCER VACCINATION IN VIVO: Intravenous Infusions of Rexin-G Followed by Reximmune-C Induce Tumor Necrosis and Recruitment of Tumor Infiltrating Lymphocytes in Cancerous Lesions (ASCO 2008) 2TARGETED GENE DELIVERY SIGNALS CANCER VACCINATION IN VIVO: Intravenous Infusions of Rexin-G Followed by Reximmune-C Induce Tumor Necrosis and Recruitment of Tumor Infiltrating Lymphocytes in Cancerous Lesions (ASCO 2008) 3
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
Medicine Products: